世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

咳止めシロップの世界市場予測 2023-2032


GLOBAL COUGH SYRUP MARKET FORECAST 2023-2032

主な調査結果 世界の咳止めシロップ市場は、予測期間2023-2032年にCAGR 3.62%を記録すると予測される。市場成長の要因は、咳止めシロップの技術革新、老人人口の増加、呼吸器疾患の有病率の上昇である。 市場イ... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
Inkwood Research
インクウッドリサーチ 		2023年9月22日 US$2,900
シングルユーザライセンス（印刷不可）
ライセンス・価格情報
注文方法はこちら 		230 英語

　

サマリー

主な調査結果
世界の咳止めシロップ市場は、予測期間2023-2032年にCAGR 3.62%を記録すると予測される。市場成長の要因は、咳止めシロップの技術革新、老人人口の増加、呼吸器疾患の有病率の上昇である。
市場インサイト
呼吸器の健康の重要性に対する意識の高まり、特にCOVID-19の大流行が、予防・治療手段としての咳止めシロップの需要を促進している。したがって、消費者が健康管理に積極的になるにつれて、咳止めシロップの市場は堅調に推移するとみられる。
さらに、咳止めシロップの製剤化における継続的な進歩が、咳止めシロップ業界に大きな変化をもたらしている。製造業者は、呼吸器疾患、アレルギー、風邪を含む様々なタイプの咳をより的確かつ効率的に緩和するために、新鮮な成分、送達技術、組み合わせを継続的に研究している。徐放性製剤のような革新的な製剤は、服用回数を減らすことで症状をよりよく管理できるようにし、長時間緩和を提供する。
例えば、ヴイックスは、ハチミツなどの天然成分にメントールやユーカリを配合した咳止めシロップを発売しており、風邪や呼吸器疾患に関連した咳を快適に緩和している。
地域別インサイト
世界の咳止めシロップ市場の成長評価には、北米、欧州、アジア太平洋、その他の地域の地理的分析が含まれる。アジア太平洋地域は、世界の咳止めシロップ市場において最大の収益を生み出すセグメントであり、呼吸器疾患の高い有病率によって、症状を緩和するための治療薬としての咳止めシロップの需要が牽引している。
競争に関する洞察
同市場には、製薬大手と中堅企業の両方が参入しており、多様な製品とサービスが提供されている。市場の大手企業には、ファイザー社、ノバルティス社、レキットベンキーザー・グループPLCなどがあります。
当レポートの内容は以下の通りです：
- 市場全体の主要調査結果の調査
- 市場ダイナミクスの戦略的内訳（促進要因、阻害要因、機会、課題）
- 全セグメント、サブセグメント、地域の3年間の過去データとともに、最低9年間の市場予測
- 市場セグメンテーション：主要セグメントの徹底的な評価と市場予測
- 地域別分析：言及された地域と国レベルのセグメントを市場シェアとともに評価
- 主要分析：ポーターのファイブフォース分析、ベンダーランドスケープ、オポチュニティマトリックス、主要購買基準など。
- 競争環境は、要因や市場シェアなどに基づく主要企業の理論的説明である。
- 企業プロファイリング：詳細な会社概要、提供する製品・サービス、SCOT分析、最近の戦略的展開など


ページTOPに戻る


目次

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
2.4.2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. PRODUCT DIVERSIFICATION IS ON THE RISE
2.5.2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
2.5.3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. PREVALENCE OF RESPIRATORY AILMENTS
3.1.2. RISING GERIATRIC POPULATION
3.1.3. INNOVATIONS IN COUGH SYRUPS
3.2. KEY RESTRAINTS
3.2.1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
3.2.2. STRINGENT REGULATORY PROTOCOLS
3.2.3. INCREASING CASES OF COUGH SYRUP DEATHS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. INCREASING SELF-MEDICATION TRENDS
4.1.2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
4.1.3. RISING POPULARITY OF E-COMMERCE CHANNELS
4.1.4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
4.1.5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.3.2. GROWTH PROSPECT MAPPING FOR ITALY
4.3.3. GROWTH PROSPECT MAPPING FOR JAPAN
4.3.4. GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
5. MARKET BY PRODUCT TYPE
5.1. COUGH SUPPRESSANTS
5.1.1. MARKET FORECAST FIGURE
5.1.2. SEGMENT ANALYSIS
5.2. COMBINATION MEDICINES
5.2.1. MARKET FORECAST FIGURE
5.2.2. SEGMENT ANALYSIS
5.3. EXPECTORANTS
5.3.1. MARKET FORECAST FIGURE
5.3.2. SEGMENT ANALYSIS
6. MARKET BY AGE GROUP
6.1. ADULTS
6.1.1. MARKET FORECAST FIGURE
6.1.2. SEGMENT ANALYSIS
6.2. ADOLESCENTS
6.2.1. MARKET FORECAST FIGURE
6.2.2. SEGMENT ANALYSIS
6.3. PEDIATRIC
6.3.1. MARKET FORECAST FIGURE
6.3.2. SEGMENT ANALYSIS
7. MARKET BY DISTRIBUTION CHANNEL
7.1. RETAIL PHARMACIES
7.1.1. MARKET FORECAST FIGURE
7.1.2. SEGMENT ANALYSIS
7.2. HOSPITAL PHARMACIES
7.2.1. MARKET FORECAST FIGURE
7.2.2. SEGMENT ANALYSIS
7.3. E-PHARMACIES
7.3.1. MARKET FORECAST FIGURE
7.3.2. SEGMENT ANALYSIS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. NORTH AMERICA COUGH SYRUP MARKET DRIVERS
8.1.3. NORTH AMERICA COUGH SYRUP MARKET CHALLENGES
8.1.4. NORTH AMERICA COUGH SYRUP MARKET REGULATORY FRAMEWORK
8.1.5. KEY PLAYERS IN NORTH AMERICA COUGH SYRUP MARKET
8.1.6. COUNTRY ANALYSIS
8.1.6.1. UNITED STATES
8.1.6.1.1. UNITED STATES COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.1.6.2. CANADA
8.1.6.2.1. CANADA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. EUROPE COUGH SYRUP MARKET DRIVERS
8.2.3. EUROPE COUGH SYRUP MARKET CHALLENGES
8.2.4. EUROPE COUGH SYRUP MARKET REGULATORY FRAMEWORK
8.2.5. KEY PLAYERS IN EUROPE COUGH SYRUP MARKET
8.2.6. COUNTRY ANALYSIS
8.2.6.1. UNITED KINGDOM
8.2.6.1.1. UNITED KINGDOM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.2. GERMANY
8.2.6.2.1. GERMANY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.3. FRANCE
8.2.6.3.1. FRANCE COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.4. ITALY
8.2.6.4.1. ITALY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.5. SPAIN
8.2.6.5.1. SPAIN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.6. POLAND
8.2.6.6.1. POLAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.7. BELGIUM
8.2.6.7.1. BELGIUM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.8. REST OF EUROPE
8.2.6.8.1. REST OF EUROPE COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. ASIA-PACIFIC COUGH SYRUP MARKET DRIVERS
8.3.3. ASIA-PACIFIC COUGH SYRUP MARKET CHALLENGES
8.3.4. ASIA-PACIFIC COUGH SYRUP MARKET REGULATORY FRAMEWORK
8.3.5. KEY PLAYERS IN ASIA-PACIFIC COUGH SYRUP MARKET
8.3.6. COUNTRY ANALYSIS
8.3.6.1. CHINA
8.3.6.1.1. CHINA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.2. JAPAN
8.3.6.2.1. JAPAN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.3. INDIA
8.3.6.3.1. INDIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.4. SOUTH KOREA
8.3.6.4.1. SOUTH KOREA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.5. INDONESIA
8.3.6.5.1. INDONESIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.6. THAILAND
8.3.6.6.1. THAILAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.7. VIETNAM
8.3.6.7.1. VIETNAM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.8. AUSTRALIA & NEW ZEALAND
8.3.6.8.1. AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.9. REST OF ASIA-PACIFIC
8.3.6.9.1. REST OF ASIA-PACIFIC COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. REST OF WORLD COUGH SYRUP MARKET DRIVERS
8.4.3. REST OF WORLD COUGH SYRUP MARKET CHALLENGES
8.4.4. REST OF WORLD COUGH SYRUP MARKET REGULATORY FRAMEWORK
8.4.5. KEY PLAYERS IN REST OF WORLD COUGH SYRUP MARKET
8.4.6. REGIONAL ANALYSIS
8.4.6.1. LATIN AMERICA
8.4.6.1.1. LATIN AMERICA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.4.6.2. MIDDLE EAST & AFRICA
8.4.6.2.1. MIDDLE EAST & AFRICA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABBOTT LABORATORIES
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCT LIST
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. ACELLA PHARMACEUTICALS
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCT LIST
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. ASTRAZENECA PLC
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCT LIST
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. CIPLA LTD
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCT LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. DABUR INDIA LTD
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCT LIST
9.2.5.3. STRENGTHS & CHALLENGES
9.2.6. GLENMARK PHARMACEUTICALS LTD
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCT LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. GSK PLC
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCT LIST
9.2.7.3. STRENGTHS & CHALLENGES
9.2.8. HIMALAYA WELLNESS COMPANY
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCT LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. KENVUE
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCT LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. MERCK KGAA
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCT LIST
9.2.10.3. STRENGTHS & CHALLENGES
9.2.11. NOVARTIS AG
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCT LIST
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. PFIZER INC
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCT LIST
9.2.12.3. STRENGTHS & CHALLENGES
9.2.13. PROCTER & GAMBLE
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. PRODUCT LIST
9.2.13.3. STRENGTHS & CHALLENGES
9.2.14. RECKITT BENCKISER GROUP PLC
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCT LIST
9.2.14.3. STRENGTHS & CHALLENGES
9.2.15. SANOFI
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCT LIST
9.2.15.3. STRENGTHS & CHALLENGES

　

ページTOPに戻る


　

Summary

KEY FINDINGS
The global cough syrup market is projected to record a CAGR of 3.62% during the forecast period, 2023-2032. The market growth is attributed to innovations in cough syrups, the growing geriatric population, and the rising prevalence of respiratory ailments.
MARKET INSIGHTS
Growing awareness about the importance of respiratory health, especially in the wake of the COVID-19 pandemic, is propelling demand for cough syrups as a preventive and therapeutic measure. Accordingly, as consumers become more proactive in managing their health, the market for cough syrups is likely to remain robust.
Further, ongoing advancements in the formulation of cough syrups have brought about a significant transformation in the cough syrup industry. Manufacturers continuously investigate fresh ingredients, delivery techniques, and combinations to provide more precise and efficient relief for various types of coughs, including those triggered by respiratory conditions, allergies, and colds. Innovations like extended-release formulas provide extended relief, enabling individuals to better manage their symptoms with reduced dosing frequency.
For example, Vicks has launched a range of cough syrups that blend natural components such as honey with menthol and eucalyptus, offering comforting relief for coughs linked to colds and respiratory problems.
REGIONAL INSIGHTS
The global cough syrup market growth evaluation includes the geographical analysis of North America, Europe, Asia-Pacific, and Rest of World. Asia-Pacific is the largest revenue-generating segment in the global cough syrup market, accredited to the demand for cough syrups as a remedy to alleviate symptoms is driven by the high prevalence of respiratory ailments.
COMPETITIVE INSIGHTS
The market includes both pharmaceutical giants and medium-sized participants, leading to a varied array of products and services. Some of the leading firms in the market include Pfizer Inc, Novartis AG, Reckitt Benckiser Group PLC, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation caters to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• The competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments



ページTOPに戻る


Table of Contents

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
2.3. SCOPE OF STUDY
2.4. CRISIS SCENARIO ANALYSIS
2.4.1. IMPACT OF COVID-19 ON COUGH SYRUP MARKET
2.4.2. IMPACT OF THE RUSSIA-UKRAINE WAR ON COUGH SYRUP MARKET
2.5. MAJOR MARKET FINDINGS
2.5.1. PRODUCT DIVERSIFICATION IS ON THE RISE
2.5.2. DOMINANCE OF OTC COUGH SYRUPS HAS DRIVEN ACCESSIBILITY
2.5.3. HEALTHCARE INFORMATION AVAILABILITY ON DIGITAL PLATFORMS INFLUENCES CONSUMER CHOICES
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. PREVALENCE OF RESPIRATORY AILMENTS
3.1.2. RISING GERIATRIC POPULATION
3.1.3. INNOVATIONS IN COUGH SYRUPS
3.2. KEY RESTRAINTS
3.2.1. OVER-DOSAGE CONCERNS DRIVING CONSUMERS TOWARD ALTERNATIVES
3.2.2. STRINGENT REGULATORY PROTOCOLS
3.2.3. INCREASING CASES OF COUGH SYRUP DEATHS
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. INCREASING SELF-MEDICATION TRENDS
4.1.2. SHIFTING CONSUMER PREFERENCE TOWARD HERBAL COUGH SYRUPS
4.1.3. RISING POPULARITY OF E-COMMERCE CHANNELS
4.1.4. COMPANIES ARE OFFERING SUGAR-FREE COUGH SYRUPS
4.1.5. GROWING INCLINATION TOWARD HOMEOPATHIC COUGH SYRUPS
4.2. PORTER’S FIVE FORCES ANALYSIS
4.2.1. BUYERS POWER
4.2.2. SUPPLIERS POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. GROWTH PROSPECT MAPPING
4.3.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.3.2. GROWTH PROSPECT MAPPING FOR ITALY
4.3.3. GROWTH PROSPECT MAPPING FOR JAPAN
4.3.4. GROWTH PROSPECT MAPPING FOR MIDDLE EAST & AFRICA
4.4. MARKET MATURITY ANALYSIS
4.5. MARKET CONCENTRATION ANALYSIS
4.6. VALUE CHAIN ANALYSIS
5. MARKET BY PRODUCT TYPE
5.1. COUGH SUPPRESSANTS
5.1.1. MARKET FORECAST FIGURE
5.1.2. SEGMENT ANALYSIS
5.2. COMBINATION MEDICINES
5.2.1. MARKET FORECAST FIGURE
5.2.2. SEGMENT ANALYSIS
5.3. EXPECTORANTS
5.3.1. MARKET FORECAST FIGURE
5.3.2. SEGMENT ANALYSIS
6. MARKET BY AGE GROUP
6.1. ADULTS
6.1.1. MARKET FORECAST FIGURE
6.1.2. SEGMENT ANALYSIS
6.2. ADOLESCENTS
6.2.1. MARKET FORECAST FIGURE
6.2.2. SEGMENT ANALYSIS
6.3. PEDIATRIC
6.3.1. MARKET FORECAST FIGURE
6.3.2. SEGMENT ANALYSIS
7. MARKET BY DISTRIBUTION CHANNEL
7.1. RETAIL PHARMACIES
7.1.1. MARKET FORECAST FIGURE
7.1.2. SEGMENT ANALYSIS
7.2. HOSPITAL PHARMACIES
7.2.1. MARKET FORECAST FIGURE
7.2.2. SEGMENT ANALYSIS
7.3. E-PHARMACIES
7.3.1. MARKET FORECAST FIGURE
7.3.2. SEGMENT ANALYSIS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. MARKET SIZE & ESTIMATES
8.1.2. NORTH AMERICA COUGH SYRUP MARKET DRIVERS
8.1.3. NORTH AMERICA COUGH SYRUP MARKET CHALLENGES
8.1.4. NORTH AMERICA COUGH SYRUP MARKET REGULATORY FRAMEWORK
8.1.5. KEY PLAYERS IN NORTH AMERICA COUGH SYRUP MARKET
8.1.6. COUNTRY ANALYSIS
8.1.6.1. UNITED STATES
8.1.6.1.1. UNITED STATES COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.1.6.2. CANADA
8.1.6.2.1. CANADA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2. EUROPE
8.2.1. MARKET SIZE & ESTIMATES
8.2.2. EUROPE COUGH SYRUP MARKET DRIVERS
8.2.3. EUROPE COUGH SYRUP MARKET CHALLENGES
8.2.4. EUROPE COUGH SYRUP MARKET REGULATORY FRAMEWORK
8.2.5. KEY PLAYERS IN EUROPE COUGH SYRUP MARKET
8.2.6. COUNTRY ANALYSIS
8.2.6.1. UNITED KINGDOM
8.2.6.1.1. UNITED KINGDOM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.2. GERMANY
8.2.6.2.1. GERMANY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.3. FRANCE
8.2.6.3.1. FRANCE COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.4. ITALY
8.2.6.4.1. ITALY COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.5. SPAIN
8.2.6.5.1. SPAIN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.6. POLAND
8.2.6.6.1. POLAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.7. BELGIUM
8.2.6.7.1. BELGIUM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.2.6.8. REST OF EUROPE
8.2.6.8.1. REST OF EUROPE COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3. ASIA-PACIFIC
8.3.1. MARKET SIZE & ESTIMATES
8.3.2. ASIA-PACIFIC COUGH SYRUP MARKET DRIVERS
8.3.3. ASIA-PACIFIC COUGH SYRUP MARKET CHALLENGES
8.3.4. ASIA-PACIFIC COUGH SYRUP MARKET REGULATORY FRAMEWORK
8.3.5. KEY PLAYERS IN ASIA-PACIFIC COUGH SYRUP MARKET
8.3.6. COUNTRY ANALYSIS
8.3.6.1. CHINA
8.3.6.1.1. CHINA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.2. JAPAN
8.3.6.2.1. JAPAN COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.3. INDIA
8.3.6.3.1. INDIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.4. SOUTH KOREA
8.3.6.4.1. SOUTH KOREA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.5. INDONESIA
8.3.6.5.1. INDONESIA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.6. THAILAND
8.3.6.6.1. THAILAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.7. VIETNAM
8.3.6.7.1. VIETNAM COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.8. AUSTRALIA & NEW ZEALAND
8.3.6.8.1. AUSTRALIA & NEW ZEALAND COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.3.6.9. REST OF ASIA-PACIFIC
8.3.6.9.1. REST OF ASIA-PACIFIC COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.4. REST OF WORLD
8.4.1. MARKET SIZE & ESTIMATES
8.4.2. REST OF WORLD COUGH SYRUP MARKET DRIVERS
8.4.3. REST OF WORLD COUGH SYRUP MARKET CHALLENGES
8.4.4. REST OF WORLD COUGH SYRUP MARKET REGULATORY FRAMEWORK
8.4.5. KEY PLAYERS IN REST OF WORLD COUGH SYRUP MARKET
8.4.6. REGIONAL ANALYSIS
8.4.6.1. LATIN AMERICA
8.4.6.1.1. LATIN AMERICA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
8.4.6.2. MIDDLE EAST & AFRICA
8.4.6.2.1. MIDDLE EAST & AFRICA COUGH SYRUP MARKET SIZE & OPPORTUNITIES
9. COMPETITIVE LANDSCAPE
9.1. KEY STRATEGIC DEVELOPMENTS
9.1.1. MERGERS & ACQUISITIONS
9.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
9.1.3. PARTNERSHIPS & AGREEMENTS
9.1.4. BUSINESS EXPANSIONS & DIVESTITURES
9.2. COMPANY PROFILES
9.2.1. ABBOTT LABORATORIES
9.2.1.1. COMPANY OVERVIEW
9.2.1.2. PRODUCT LIST
9.2.1.3. STRENGTHS & CHALLENGES
9.2.2. ACELLA PHARMACEUTICALS
9.2.2.1. COMPANY OVERVIEW
9.2.2.2. PRODUCT LIST
9.2.2.3. STRENGTHS & CHALLENGES
9.2.3. ASTRAZENECA PLC
9.2.3.1. COMPANY OVERVIEW
9.2.3.2. PRODUCT LIST
9.2.3.3. STRENGTHS & CHALLENGES
9.2.4. CIPLA LTD
9.2.4.1. COMPANY OVERVIEW
9.2.4.2. PRODUCT LIST
9.2.4.3. STRENGTHS & CHALLENGES
9.2.5. DABUR INDIA LTD
9.2.5.1. COMPANY OVERVIEW
9.2.5.2. PRODUCT LIST
9.2.5.3. STRENGTHS & CHALLENGES
9.2.6. GLENMARK PHARMACEUTICALS LTD
9.2.6.1. COMPANY OVERVIEW
9.2.6.2. PRODUCT LIST
9.2.6.3. STRENGTHS & CHALLENGES
9.2.7. GSK PLC
9.2.7.1. COMPANY OVERVIEW
9.2.7.2. PRODUCT LIST
9.2.7.3. STRENGTHS & CHALLENGES
9.2.8. HIMALAYA WELLNESS COMPANY
9.2.8.1. COMPANY OVERVIEW
9.2.8.2. PRODUCT LIST
9.2.8.3. STRENGTHS & CHALLENGES
9.2.9. KENVUE
9.2.9.1. COMPANY OVERVIEW
9.2.9.2. PRODUCT LIST
9.2.9.3. STRENGTHS & CHALLENGES
9.2.10. MERCK KGAA
9.2.10.1. COMPANY OVERVIEW
9.2.10.2. PRODUCT LIST
9.2.10.3. STRENGTHS & CHALLENGES
9.2.11. NOVARTIS AG
9.2.11.1. COMPANY OVERVIEW
9.2.11.2. PRODUCT LIST
9.2.11.3. STRENGTHS & CHALLENGES
9.2.12. PFIZER INC
9.2.12.1. COMPANY OVERVIEW
9.2.12.2. PRODUCT LIST
9.2.12.3. STRENGTHS & CHALLENGES
9.2.13. PROCTER & GAMBLE
9.2.13.1. COMPANY OVERVIEW
9.2.13.2. PRODUCT LIST
9.2.13.3. STRENGTHS & CHALLENGES
9.2.14. RECKITT BENCKISER GROUP PLC
9.2.14.1. COMPANY OVERVIEW
9.2.14.2. PRODUCT LIST
9.2.14.3. STRENGTHS & CHALLENGES
9.2.15. SANOFI
9.2.15.1. COMPANY OVERVIEW
9.2.15.2. PRODUCT LIST
9.2.15.3. STRENGTHS & CHALLENGES

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（薬学的薬物）の最新刊レポート

Inkwood Research社のその他分野での最新刊レポート

本レポートと同じKEY WORD（）の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


Inkwood Research社はどのような調査会社ですか?


Inkwood Researchは世界40ヶ国以上の国を対象に広範な市場を調査し、世界市場全体を調査したレポートに加え、アジア太平洋地域、欧州、北米などの主要地域や主要国毎のレポートも数多く出版してい... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21　10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.